Scalper1 News
Specialty drugmaker Auxilium Pharmaceuticals said Wednesday that it will review an unsolicited $2.2 billion takeover bid from Endo International, announced late Tuesday. But the board adopted a shareholder-rights or “poison pill” plan to deflect a hostile takeover attempt, and many analysts argued Endo will have to pay more to win Auxilium. The market seemed to be rooting for it to happen. Auxilium (AUXL) stock surged 45% to 31.17 , above the Scalper1 News
Scalper1 News